FDA OKs Abbott’s Alinity

The FDA approves Abbott’s (ABT -0.2%) Alinity system for screening blood and plasma. The company says the instrument can process up to 600 tests per hour while requiring less space than other systems in its class.

https://seekingalpha.com/news/3477121-fda-oks-abbotts-alinity

Weight Watchers upped to Neutral from Underweight by JPMorgan

Target to $22 from $17

https://www.benzinga.com/stock/WW/ratings

Stryker target upped to $232 from $200 at Credit Suisse

Maintains Outperform

https://www.benzinga.com/stock/SYK/ratings

Spectrum Pharma started at Buy by B. Riley

Target $18

https://www.benzinga.com/stock/SPPI/ratings

Navidea started at Buy by Maxim

https://www.benzinga.com/stock/NAVB/ratings

Immunic started at Buy by Chardan

Target $40

https://www.benzinga.com/stock/IMUX/ratings

National Vision started at Buy by Goldman Sachs

Target $33

https://www.benzinga.com/stock/EYE/ratings